September 14, 2016 News by Patricia Inacio, PhD #ECTRIMS2016 – Cognitive Problems in MS Patients Linked to Lower Income, Study Reports In a recent talk, titled “Income and cognitive impairment among multiple sclerosis patients,” scientists investigated how cognitive impairment impacts the life of patients with multiple sclerosis (MS), and reported significant differences in income that correlated with levels of MS-cognitive deficit. These findings were recently presented at the 32nd Congress of the European Committee for…
February 18, 2016 News by Patricia Silva, PhD Treadmill Exercise Benefits MS Patients, According to Study Presented at ACTRIMS Forum Brian M. Sandroff from the Kessler Foundation and Robert W. Mot with the University of Illinois will present the results of a study on the effects of exercise in patients with multiple sclerosis (MS) today, Feb.18, at the Americas Committee for the Treatment and Research in Multiple Sclerosis (ACTRIMS)…
February 1, 2016 News by Margarida Azevedo, MSc MS Cognitive Impairment Traced to Synapse Damage in Hippocampus Researchers identified a new mechanism in the progression of multiple sclerosis (MS) that might explain the cognitive impairment and decline observed in these patients — a decline not directly associated with disease’s hallmarks of motor control loss, and one not currently addressed by the immunosuppressive drugs used to treat MS. The study, published…
November 23, 2015 News by admin Multiple Sclerosis Patients Show Improved Reactions with Treadmill Exercise Several studies have shown that exercise can improve movement in multiple sclerosis (MS), but new research indicates that it specifically may also improve reaction time, a measurement of cognitive impairment. The study, titled “Acute effects of varying intensities of treadmill walking exercise on inhibitory control in persons with…
September 22, 2015 News by Patricia Inacio, PhD Inhibiting LINGO-1 Protein is a Potential Future Treatment for Cognitive Impairment in MS Patients In a new study entitled “LINGO-1 antibody ameliorates myelin impairment and spatial memory deficits in experimental autoimmune encephalomyelitis mice”, a team of scientists report that the loss of myelin in multiple sclerosis (MS) patients’ brains contributes to their cognitive impairment. They showed that inhibiting protein LINGO-1 can…
July 13, 2015 News by Patricia Silva, PhD New MS Study Shows TYSABRI Improves Cognitive Impairment Researchers at Spedali Civili of Brescia in Italy recently published findings in the journal PLoS One that Biogen’s Tysabri (natalizumab) can improve cognitive impairment in patients with relapsing remitting multiple sclerosis (RRMS) over the course of at least three years. The study is entitled “Natalizumab Significantly…
